詳細信息
- ;萘夫托地;鹽酸萘哌地爾;1-(2-甲氧基)-4-[3-(1-萘氧基)-2-羥丙基]-哌嗪鹽酸鹽;1-[4-(2-甲氧苯基)-哌嗪]-3-(1-萘氧基)-2-丙醇鹽酸鹽;荼哌地爾;
- Naftopidil
- ;4-(2-Methoxyphenyl)-a-[(1-naphthalenyloxy)methyl]-1-piperazineethanol dihydrochloride;4-(2-Methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol dihydrochloride;Naftopidil dihydrochloride;1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol;1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol dihydrochloride;
- InChI=1/C24H28N2O3.2ClH/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23;;/h2-12,20,27H,13-18H2,1H3;2*1H
- 127 °C
- 602.8°C at 760 mmHg
- 318.3°C
- methanol: >10 mg/mL
- 萘哌地爾 CAS No 57149-07-2 產品性狀 白色結晶粉末 產品規格≥ 99% 產品用途 輕中度原發性高血壓及良性前列腺增生治療 Naftopidil CAS No: 57149-07-2 Characters: white crystal powder Specification: ≥ 99% Usage: for the treatment of benign prostatic hyperplasia
- CAS NO：57149-07-2
產品規格：≥99%
免責聲明：以上所展示的信息由企業自行提供，內容的真實性、準確性和合法性由發布企業負責，化工網對此不承擔任何保證責任。我們原則上建議您選擇化工網高級會員或VIP會員。